Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK Comparison of Ibuprofen Suspensions (Nurofen vs Algifor)
NCT02503085Phase 1Completed
- Sponsor
- Reckitt
- Start
- Jun 2015
- Primary completion
- Aug 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of ibuprofen in fever and pain (4 arms), sponsored by Reckitt. Primary endpoints: Maximum Plasma Concentration at Day 1 and Area Under the Plasma Concentration-time Curve From Administration to Last Quantifiable Concentration at Day 1. Started Jun 2015; status: completed.
02
Drugs
ibuprofen
03
Conditions
feverpain
Beyond the preview
Go deeper on NCT02503085.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02503085.